This site uses cookies to bring you the best experience. Find out more
Skip to main content

Discover our world-class facilities

With a development pipeline of over 600,000 sq ft due to be
delivered by the end of 2026, The Oxford Science Park is the
ideal home for occupiers to expand.

Discover the park

 

Who's Here

Close to 100 pioneering organisations

With more than 3000 employees


Who's Here

£2bn Raised

By Occupiers Since January 2020


Explore Careers

With a development pipeline of over 600,000 sq ft

due to be delivered by the end of 2026, The Oxford Science Park is the ideal home for occupiers to expand.


Our Developments

Six

New buildings planned


Explore the Sitemap

Rare and Major Diseases

Being researched


Who's Here

LATEST NEWS

Sitryx initiates Phase1 clinical trial of potential disease-modifying treatment for atopic dermatitis SYX-5219

24 . 03 . 25

Sitryx Therapeutics, a clinical-stage biopharmaceutical company developing novel oral therapies to restore immune balance in autoimmune and inflammatory disease, has announced the initiation of its first-in-human Phase 1a clinical trial evaluating...

Read More

The Daubeny Project

Imaginative design, inspiring spaces.